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In this investigation, we studied the expression and 
localization of rat prostaglandin F (FP) receptor in uterine 
tissues of rats on gestational Days 10, 15, 18, 20, 21, 21.5 and 
postpartal Days 1 and 3 using Western blotting analysis, 
real-time PCR, and immunohistochemistry. A high level of 
immunoreactivity was observed on gestational Days 20, 21, 
and 21.5 with the most significant signals found on Day 20. 
FP receptor protein was expressed starting on gestational 
Day 15, and a fluctuating unsteady increase was observed 
until delivery. Uterine FP receptor mRNA levels were low 
between Days 10 and 18 of gestation (p ＜ 0.05). The 
transcript level increased significantly on Day 20 and 
peaked on Day 21.5 just before labor (p ＜ 0.05). There was 
a positive correlation between FP receptor mRNA 
expression and serum estradiol levels (rs = 0.78; p ＜ 0.01) 
along with serum estradiol/progesterone ratios (rs = 0.79; p 
＜ 0.01). In summary, we observed an increase FP receptor 
expression in rat uterus with advancing gestation, a marked 
elevation of expression at term, and a concominant decrease 
during the postpartum period. These findings indicate a role 
for uterine FP receptors in the mediation of uterine 
contractility at term. 
Keywords: immunohistochemistry, pregnancy, prostaglandin F 
receptor, rat, uterus
Introduction
　The principal site of action for prostaglandins (PGs) 
during labor is the myometrium, where these factors 
modulate contractility via specific receptors [1,4,6,21]. 
Activation of the myometrium involves increased 
expression of genes that permit the myometrium to 
contract during labor. These myometrial (or uterine) 
activation proteins (UAPs) include the prostaglandin F2α 
(PGF2α), prostaglandin E2 (PGE2), and prostaglandin F 
(FP) receptors; prostaglandin E receptor 1e4 (EP1e4), 
oxytocin receptor, and PG endoperoxide H synthase-2 
[15]. Uterine stimulators include oxytocin and 
prostaglandins [15]. 
　PGs (especially PGF2α) produced by intrauterine tissues 
associated with pregnancy (amnion, chorion, placenta, 
decidua, and myometrium) play important roles in all 
physiological processes of parturition. Parturition includes 
five separate but integrated physiological events: 
membrane rupture, cervical dilatation, myometrial 
contractility, placental separation, and uterine involution. 
Increasing evidence supports a role for PGs in each of these 
events [4,11,16]. The objective of this study was to 
evaluate the expression and localization of the FP receptor, 
a significant UAP, in uterine tissues of rats during mid to 
late pregnancy and postpartum (PP) using Western blotting 
analysis, real-time polymerase chain reaction (RT-PCR), 
and immunohistochemistry with specific antibodies 
against the FP receptor. 
Materials and Methods
Animals
　Forty-eight adult female Sprague Dawley rats weighing 
200∼250 g were purchased from Harlan Laboratories 
(The Netherlands). Animals were maintained with a 12-h 
light/dark schedule, and received standard experimental 
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rat diet (Korkuteli Food Industry, Turkey) and water ad 
libitum.  The rats were randomly divided into eight groups 
(six animals per group) and the uterine horns were excised, 
and pups and placentas were discarded  at 09：00 h on Day 
10, 15, 18, 20, or 21 of gestation; Day 21.5 (at labor), or the 
1st or 3rd day postpartum (PP1 or PP3). The day of mating 
was designated as Day 1 of pregnancy with delivery 
occurring between 21：00 h on Day 21 and 09：00 h on 
Day 22. Samples from the antimesometrial region of one 
uterine horn were immersion fixed in neutral 4% 
formaldehyde for immunohistochemical analysis or snap 
frozen in liquid nitrogen and stored at −80oC until 
real-time quantitative reverse transcription PCR 
(qRT-PCR) examination of gene expression and Western 
blot analysis were conducted. mRNA levels were 
measured with an RT-PCR assay. Venous blood samples 
(1.0 mL) were obtained from the right atrium prior to 
surgery on Day 10, 15, 18, or 21 of gestation, PP1, or PP3. 
The samples were stored at −20oC for estradiol and 
progesterone measurements. All procedures involving the 
use of animals were approved by the Gazi University 
Animal Experiments Local Ethics Committee (approval 
no: 08.16; Turkey).
Immunohistochemical analysis
　A peroxidase anti-peroxidase (PAP) immunocytochemical 
staining technique was used to analyze tissue samples. For 
immunohistochemical analysis uterine horn were 
immersion fixed in neutral 4% formaldehyde and then 
dehydrated in a series of graded alcohols (50, 60, 70, 80, 90 
and 100% ethanol; Merck, Germany). After passing through 
xylene (Merck) and then the tissue were embedded in 
parafin (Shandon, Thermo Fisher Scientific, USA). For this 
procedure, serial paraffin sections were cut  with  microtome 
(Leica, Germany) at a thickness of 4∼5 μm and placed onto 
poly-L-lysine-coated slides (Gerhard Menzel, Germany).  
After deparaffinization in xylene and rehydration with  
reduced ethanol series (80, 90, 100%; Merck) endogenous 
peroxidase activity was inhibited by incubation with 3% 
hydrogen peroxide in absolute methanol for 10 min. After 
washing in phosphate buffered saline, the sections were 
incubated with  10% nonimmune serum (Cat. no: 85-9043, 
blocking solution, Histostain-Plus Kit, horseradish- 
peroxidase [HRP], broad spectrum; Invitrogen, USA) for 10 
min to eliminate nonspecific staining. The tissues were then 
incubated with  goat polyclonal antibodies (diluated to ratio 
1 : 100) against the FP receptor (PGF2αR, N-18, antibody; 
Santa Cruz Biotechnology, USA) for 6 h and exposed to a  
biotinylated secondary antibody (diluated to ratio 1 : 100, 
Cat. no: 85-9043, Histostain-Plus Kit, HRP, broad spectrum 
second antibody; Invitrogen) for 10 min. Immunoreactivity 
was detected with an HRP-streptavidin complex (Cat. no: 
85-9043, HRP-Streptavidin, Histostain-Plus Kit, HRP, 
broad spectrum; Invitrogen) using Diaminobenzidine 
Histostain-Plus Kit chromogen (broad spectrum; 
Invitrogen) as a marker. The sections were counterstained 
with Mayer's hematoxylin (for 2 min, dehydrated with 
ethanol series 60, 70, 80, 90, 96, 100%) and  after passing 
xylene (Merck) for 2 times. Slides were mounted with 
entellan (Merck). For the negative controls, the primary 
antibody was replaced with PBS. For the immunoglobulin 
G (IgG) control, 10% nonspecific rabbit serum (Cat.no: 
85-9043, blocking solution, Histostain-Plus Kit, HRP, 
broad spectrum; Invitrogen)  was used instead of the 
primary antibody. All incubation steps were carried out at 
room temperature in a humidified chamber. 
Immunohistochemical staining results were obtained using 
an image processing and analysis system (QWin image 
analysis tool kit; Leica Microsystems, Germany) linked to a 
Leica DM4000 light microscope. The staining intensity was 
scored as negative (−), weak (+), moderate (++), or strong 
(+++).
Western blot analysis
　Proteins extracted from uterine tissues were subjected to 
Western blot analysis. Equivalent masses (0.3 g) of tissue 
were taken from the uterus. The tissue samples were 
homogenized using a mechanical homogenizer (IKA, 
Germany) in lysis buffer (1% NP-40 (Sigma, USA), 50 
mmol/L Tris [pH 7.5], 50 mmol/L EDTA (Sigma), 1% 
SDS, 1% sodium deoxycholate, 1% Triton X-100, 1 
mmol/L PMSF (Sigma), 10 μg/mL aprotinin (Sigma), and 
1 μg/mL leupeptin (Sigma) with a 2 μg/mL protease 
inhibitor cocktail (Sigma). The homogenates were 
centrifuged at 14,000 g for 10 min at 4oC in a 
microcentrifuge (Rotina 35R; Hettich, UK), and the 
supernatants were taken for analysis. 
　Protein concentration of the samples was determined 
using the bicinchoninic acid method (BCA protein assay 
kit; Pierce, USA) with bovine serum albumin (BSA; 
Pierce) as a standard. Next, 50 μg of protein were separated 
by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The separated proteins were 
transferred to a polyvinylidene fluoride (PVDF) membrane 
(Pierce) using an electroblotter (OWL VEP-2; Thermo 
Fischer Scientific) at 350 mA for 2 h. The membrane was 
blocked using Tris-buffered saline containing 0.1% 
Tween-20 (TBST) with 5% nonfat dry milk (Cell Signaling 
Technology, USA) at 4oC for 1 h. The blocked membranes 
were incubated overnight at 4oC with primary antibodies 
against PGF2αR (anti-goat, N-18 1 : 1000; Santa Cruz 
Biotechnology) and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; anti-rabbit, 1 : 1000; Sigma) 
diluted in TBS containing 5% nonfat milk powder. GAPDH 
was used as a loading control. The membranes were washed 
three times for 10 min each in TBST (20 mM Tris-HCl, 0.5 
M NaCl, 0.05% Tween-20, pH 8.0) and then incubated with 
the HRP-conjugated anti-rabbit IgG secondary antibody (1 
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Table 1. Gene-specific primer sequences and probe numbers
Gene Forward primer Reverse primer UPL probe number
ACTB
PGF2α receptor
5´ CCCGCGAGTACAACCTTCT 3´
5´ GAGATTTAGACGGAAGTCGAAGG 3´
5´ CGTCATCCATGGCGAACT 3´
5´ GTGATCACCAGGCCACTAGC 3´
17
112
: 5000 dilution; Santa Cruz Biotechnology) for 2 h at room 
temperature. The membrane was then incubated with 
chemiluminescence substrate (ECL Western Blotting 
Substrate; Pierce) for 5 min and the proteins were detected 
with an enhanced chemiluminescence system (Amersham, 
USA). Chemiluminescent signals were captured by X-ray 
film (Pierce) imaging.
RNA extraction and reverse transcription
　Total RNA was isolated from uterine tissues using a 
Trizol reagent system (peqGOLD TriFastTM; PEQLAB, 
Germany). To avoid DNA contamination, we made some 
modifications to the manufacturers’ instructions. The 
RNA pellets were treated with approximately 1∼5 U 
RNase-free DNase (DNaseI; Roche Diagnostics, 
Germany) per μg RNA and incubated at 37oC for 30 min 
before being washed with 70% ethanol to prevent DNA 
contamination. After the ethanol was removed by 
air-drying, the RNA pellets were dissolved in 10∼30 μL 
of RNase- and DNase-free water (Sigma).  Isolated RNA 
was kept at −80oC. The yield and quality of RNA from 
each sample was determined by measuring the absorbance 
at 260 and 280 nm using a Nanodrop spectrophotometer 
(NanoDrop ND-1000; Thermo Fisher Scientific). Equal 
amounts of RNA were used for reverse transcription. 
Complementary DNA (cDNA) was reverse transcribed 
from 1 μg of total RNA using a Transcriptor First Strand 
cDNA synthesis kit (Roche Diagnostics) according to the 
manufacturer’s instructions. This process was performed 
in a PCR Sprint thermocycler (Thermo Hybaid, Germany).
qRT-PCR analysis
　FP mRNA expression was measured using qRT-PCR with 
a LightCycler instrument (Roche Diagnostics). Beta-actin 
(ACTB), a housekeeping gene, was used to normalize FP 
mRNA expression levels. Probes and intron spanning 
primers for each assay were designed using the Universal 
Probe Library (UPL) Assay Design Center (Roche Applied 
Science, Germany). Gene-specific primer sequences 
(exon-exon junctions to allow discrimination between 
cDNA and genomic DNA) and UPL numbers are provided 
in Table 1. 
　A volume of 2 μL of cDNA product was subjected to 
real-time PCR in a 10 μL total reaction mixture containing 
2.5 μL of TaqMan Universal PCR Master Mix (Roche 
Diagnostics), 0.5 μL sense and antisense primers, 0,1 μL 
probe and template cDNA. The reaction mixture was 
prepared in a 96-well plate (LightCycler 480 Multiwell 
Plates 96; Roche Applied Science) and a qRT-PCR was 
performed using a LightCycler 480 instrument (Roche 
Diagnostics). After a single step of initial denaturation at 
95oC for 10 min, followed by 55 cycles of 10 sec at 95oC, 
20 sec at 65oC and 1 sec at 60oC for annealing and 30 sec at 
40oC for cooling. Negative control reactions lacked 
template cDNA. Each sample was analyzed in triplicate. In 
order to determine amplification efficiencies of the target 
genes, standard curves were constructed for the samples 
used in a series of dilutions for analyzing both the gene of 
interest (GOI) and the housekeeping gene (ACTB). GOI 
(FP) and ACTB amplification efficiencies were 
approximately equal. The results were analyzed with 
LightCycler Software version 3.5 (Roche Diagnostics). FP 
gene expression analysis was performed using the Relative 
Expression Software Tool 2005 (REST; Qiagen, the 
Netherlands). Significant differences in mRNA levels 
were analyzed by a pairwise fixed reallocation 
randomization test as a statistical model included in the 
REST developed for group-wise comparison and 
statistical analysis of relative expression results.
Measurement of hormone levels
　Serum estradiol and progesterone levels were measured 
with an enzyme-linked immunosorbent assay (ELISA) 
sandwich method (Cayman Chemical, USA). Monoclonal 
antibodies specific for rat estradiol and progesterone were 
used to precoat 96-well plates. Each plate contained a 
minimum of two blanks, two nonspecific binding wells, 
two maximum binding wells and an eight point standard 
curve run in duplicate. 50 μL of serum sample was added 
per well. Each sample was assayed at a minimum of two 
dilutions. Each dilution was assayed in duplicate. Standart 
marker dilution factors were between 6.6-4,000 pg/mL and 
7.4-1,000 pg/mL for estradiol and progesterone, 
respectively. The samples and standards were evaluated 
according to the manufacturer’s instructions. Absorbance 
at 450 nm was recorded using an ELISA plate reader 
(model 680 Microplate Reader; Bio-Rad Laboratories, 
USA).
Statistical analysis
　All data were analyzed using SPSS statistical software 
(ver. 15.0 for Windows; SPSS, USA). Significant 
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Table 2. Prostaglandin F receptor distribution and staining intensity in pregnant rat uteri 
Groups SEE GEE CT VESM LM CM
Day 10 (n = 6)
Day 15 (n = 6)
Day 18 (n = 6)
Day 20 (n = 6)
Day 21 (n = 6)
Day 21.5 (n = 6)
PP1 (n = 6)
PP3 (n = 6)
+
++
+++
+++
+++
+++
++
+
+
++
++
+++
+++
+++
+
+
++
++
++
+++
++
++
+
+
−
−
−
+++
++
++
+
+
+
++
++
+++
+++
+++
+
+
−
+
+
+++
+++
+++
+
+
SEE: superficial endometrial epithelium, GEE: glandular endometrial epithelium, CT: connective tissue in the lamina propria, VESM: 
vascular endothelial and smooth muscle cells, LM: longitudinal myometrium, CM: circular myometrium.
Fig. 1. Myometrial samples from Day 10 (A), Day 15 (B), and 
Day 21 (C)  of gestation as well as postpartum Day 3 (PP3; D) 
showing FP receptor immunostaining in the endometrial 
epithelium, connective tissue of the lamina propria, and vascular
endothelial and smooth muscle cells. İmmunperoxidase and 
Hematoxylin stain, ×400.
differences in mRNA expression were analyzed with a 
pairwise fixed reallocation randomization test as a 
statistical model included in the REST software developed 
for group-wise comparison and statistical analysis of 
relative expression results. The p values ＜ 0.05 were 
considered significant.
Results
Immunohystochemical and Western blot analyses
　 An immunoreaction specific for the FP receptor was 
observed in all specimens studied. The FP receptor was 
detected by immunohistochemistry in cells and apical cell 
membranes in the superficial and glandular epithelium, 
connective tissue cells in the lamina propria, and vascular 
endothelial and smooth muscle cells. In addition, FP 
receptor expression was predominantly localized to 
myocytes in both the circular and longitudinal layers of the 
myometrium. A marked change in overall staining intensity 
was observed according to gestational age (Table 2). Overall 
immunoreactivity was lowest on Day 10 and increased on 
Days 15 and 18. A high level of immunoreactivity was 
observed on Days 20, 21, and 21.5 with the strongest signals 
found on Day 20 followed by a lower degree of reactivity 
during the postpartum period. Involvement of the vascular 
endothelial and smooth muscle cells was first observed on 
Day 20. Moderate immunostaining on Days 20, 21, and 21.5 
was followed by weak staining on PP1 and PP3. On Days 
20, 21, and 21.5, strong signals in both the circular and 
longitudinal layers of the myometrium were observed. In 
contrast, stronger staining was observed in the outer 
longitudinal myometrial layer compared to the inner 
circular muscle layer on previous days of gestation and the 
postpartum period (Fig. 1). 
　Western blot analyses demonstrated that no FP receptor 
protein was expressed on the 10th day of gestation. 
However, the protein was expressed starting on the 15th 
day of gestation, and a fluctuating unsteady increase was 
observed until delivery. The greatest FP receptor protein 
levels were observed during the prenatal period (Day 21.5; 
Fig. 2). During the postnatal period, protein expression 
decreased steadily. 
qRT-PCR analysis findings
　Uterine FP receptor mRNA levels were low between 
Days 10 and 18 of gestation (p ＜ 0.05). The level of FP 
transcript increased significantly on Day 20 and peaked on 
Day 21.5 just before labor (p ＜ 0.05). After delivery, FP 
receptor mRNA levels fell rapidly through PP1 and PP3 
compared to Day 21.5 (p ＜ 0.05; Fig. 3). The present study 
demonstrated that FP receptor mRNA expression was 
increased in the rat uterus during pregnancy, reached 
maximal levels during labor, and declined postpartum. 
These results may indicate a role for the PGF2α receptor in 
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Fig. 3. Relative mRNA expression of the PGF2α receptor. Bars 
represent PGF2α receptor mRNA expression levels normalized 
to that of ACTB and relative to 10th day using the REST and 
2-ΔΔCT. An asterisk indicates that the value was significantly 
different from the 10th day of gestation (p ＜ 0.05). An asterisk 
indicates that the value was significantly different from the 21.5st
day of gestation (p ＜ 0.05). 
Fig. 4. Estradiol and progesterone levels in rats during late 
pregnancy and postpartum.
Fig. 5. Correlations between steroid hormone levels and FP receptor mRNA expression.
Fig. 2. Western blots showing FP receptor expression in 
intrauterine tissues (gestation Day 10, 15, 18, 20, 21, and 21.5 as 
well as PP1 and PP3).
the final cervical ripening during gestation and parturition.
Hormonal analysis
　Serum progesterone levels increased from Day 10 through 
Day 18. These levels declined after Day 18 through PP3. 
Serum estradiol levels increased gradually from Day 10 
through Day 21 and declined during the postpartal period 
(Fig. 4). Post-hoc tests revealed significant differences 
between Day 18∼21; Day 21-PP1, and PP1-PP3 (p ＜ 
0.01). There was a positive correlation between FP 
receptor mRNA levels and serum estradiol concentrations 
(rs = 0.78; p ＜ 0.01) and serum estradiol/progesterone 
ratios (rs = 0.79; p ＜ 0.01). In contrast, serum 
progesterone levels (Fig. 5) were negatively correlated 
with FP receptor mRNA expression (rs = −0.44; p ＜ 
0.01).
Discussion
　 The PGs are recognized as the ‘triggers’ of labor [5] 
because the myometrium contracts in response to 
exogenous PGs both in vivo and in vitro [7,19], PG synthetic 
enzymes and levels in tissues and fluids increase before or at 
the time of labor, and inhibitors of PG synthesis delay birth 
and prolong pregnancy [15]. The current study clearly 
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demonstrated that the FP receptor mRNA levels in rat uterus 
were low between Days 10 and 18 of gestation, significantly 
increased on Day 20, peaked during parturition, and fell 
rapidly after delivery. This pattern of FP receptor expression 
is similar to those previously reported for the myometrium 
[4,17] and entire uterus [2]. Responsiveness of the rat 
myometrium to PGF2α increases from Day 18 throughout 
the latter part of gestation [7]. Increases in FP receptor 
expression were reported to increase sensitivity of the 
myometrium to PGF2α action at term, even in the absence 
of increased PGF2α concentrations [4]. Accordingly, the 
results of the present investigation support the hypothesis 
that an increase in myometrial expression of the FP receptor 
is an important component of labor initiation.
　Prostaglandin F2α exerts well-known effects on 
myometrial contractility and inhibits labor [11]. Parturition 
consists of five separate but integrated physiological events: 
myometrial contractility, membrane rupture, cervical 
dilatation, placental separation, and uterine involution [16]. 
Increasing evidence supports a role for PGs in each of these 
events [15,16]. Recently, FP receptor protein was identified 
in human amnion epithelium and mesoderm, chorion 
trophoblasts, and decidua by immunohistochemistry, and it 
was suggested that the induction of FP receptor expression 
at term may facilitate the contribution of the decidua to 
parturition [12]. In the present study, immunostaining 
intensity scores for the FP receptor observed in the 
endometrial epithelium, connective tissue of the lamina 
propria, and vascular endothelial and smooth muscle cells 
significantly increased from mid-pregnancy to term and 
decreased during the postpartal period. These observations 
serve as histological evidence indicating a physiological 
function of endometrial FP in rat uterus. Additionally, the 
results also support the recent concept that pregnant rat 
endometrium is an important regulator of myometrial 
contractility. 
　Interestingly, we observed a difference in immunostaining 
intensity between two muscular layers of myometrium on 
Day 10, 15, and 18 of gestation and during the postpartum 
period with stronger signals in the outer longitudinal 
muscles compared to the inner circular muscles. The 
myometrium is the muscular part of the uterus that is 
responsible for generating the force necessary to expel the 
fetus at term. It is composed of three well-defined layers. 
The circumferentially oriented smooth muscle cells of the 
circular muscle in the myometrium surround the 
endometrium. The smooth muscle cells of the outer 
longitudinal muscle layer of the myometrium align along 
the long axis of the uterus. These muscle layers exhibit 
distinct phenotypes during pregnancy. Differential 
production of prostaglandins [9] as well as different 
responses to stretch, noradrenaline, and estrogen 
stimulation in circular versus longitudinal muscle have 
been reported [10,13]. Thompson et al. [22] described 
certain characteristic differences between the responses of 
circular and longitudinal muscles to PGF2α. Using 
contraction recordings, these authors demonstrated that the 
maximum response to PGF2α in longitudinal muscles was 
not different on Days 15 and 21 of gestation, and the half 
maximal effective concentration (EC50) for PGF2α did not 
change in longitudinal muscles between Days 15 and 21. 
However, the magnitude of both the threshold and 
maximum responses of the circular muscles progressively 
increased between Days 15 and 21, and the EC50 for circular 
muscles declined between Days 17 and 21. The functional 
significance of the differences between circular and 
longitudinal muscles is not entirely clear. It has been 
suggested that weak, high-frequency contractions of the 
circular layer and localized, infrequent contractions of the 
longitudinal layer during gestation prevent movement of 
the fetuses toward the cervix [13]. Observing strong 
immunreactivity in both muscle layers on Day 20, 21, and 
21.5 in our study may indicate differential FP expression in 
circular and longitudinal myometrial muscles in pregnant 
rats. Functional studies testing this hypothesis are lacking. 
Al-Matubsi et al. [1] did not observe any marked change in 
staining intensity with gestational age or labor. However, 
this study was conducted in rats on gestation Days 16∼22.
　Few data have been published on the regulation of FP 
receptor expression in the uterus during pregnancy [14]. FP 
receptor mRNA expression in the rat uterus appears to be 
related to changes in ovarian steroid concentrations [17]. 
Progesterone is the hormone responsible for maintaining 
uterine smooth muscle quiescence during pregnancy. 
Progesterone levels decline after Day 19 of pregnancy 
followed by simultaneous increases in the levels of estradiol 
and prostaglandin F after Day 20 [18]. In accordance with 
previous reports [11,21], serum progesterone levels 
increased from Day 10 through Day 18 followed by a 
decline after Day 18 through PP3 in the current study. Serum 
estradiol levels increased gradually from Day 10 through 
Day 21 and declined during the postpartal period. FP 
receptor mRNA levels were positively correlated with 
serum estradiol concentrations and serum estradiol/ 
progesterone ratios. On the other hand, serum progesterone 
levels were negatively correlated with FP receptor mRNA 
expression. Similarly, Dong and Yallampalli [8] observed 
antagonistic effects of ovarian steroids on FP expression. 
Progesterone appears to block the stimulatory effects of 
estrogen on FP receptor expression. Increases in 
myometrial FP receptor mRNA levels have always been 
correlated with a decline in progesterone concentrations 
whether occurring naturally before the onset of term labor or 
artificially induced by ovariectomy [3,8]. Furthermore, 
exogenous progesterone successfully inhibits increases in 
the level of myometrial FP receptor mRNA associated with 
labor whether at term or during premature induction by 
ovariectomy [8]. The mechanisms underlying the inhibitory 
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effect of progesterone on myometrial FP receptor mRNA 
expression are largely unknown [17]. In contrast, FP 
receptor levels are increased by estradiol in pregnant and 
nonpregnant rat uterus [8].
　In conclusion, our findings support the speculation that 
increased myometrial expression of the FP receptor is an 
important component of labor initiation. In addition, the 
ratio of estrogens to progesterone levels changes at term. 
These results suggested that steroid hormone-induced 
changes in PGF receptor expression may mediate the 
effects of steroid hormones on uterine contractility.
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